Jaguar Health (JAGX) Change in Inventory (2015 - 2026)
Jaguar Health (JAGX) posted quarterly Change in Inventory of -$780000.0 for Q1 2026, down 473.21% year-over-year from $209000.0 in Q1 2025, and down 2589.66% quarter-over-quarter from -$29000.0 in Q4 2025.
Jaguar Health (JAGX) Change in Inventory (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Change in Inventory for 12 consecutive years, with -$780000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory fell 473.21% year-over-year to -$780000.0; the TTM figure through Mar 2026 stood at -$735000.0 (down 147.91% YoY), while the FY2025 annual figure was $254000.0, down 78.03% from the prior year.
- Change in Inventory slipped to -$780000.0 in Q1 2026 per JAGX's latest filing, from -$29000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $1.9 million in Q2 2022 and bottomed at -$780000.0 in Q1 2026.
- Historically, Change in Inventory has averaged $289352.9 across 5 years, with a median of $118000.0 in 2024.
- Annual changes were most pronounced in 2023 — Change in Inventory soared 7645.45% — and 2026, when it slumped 473.21%.
- Jaguar Health's Change in Inventory stood at $423000.0 in 2022, then soared by 91.49% to $810000.0 in 2023, then dropped by 17.16% to $671000.0 in 2024, then sank by 104.32% to -$29000.0 in 2025, then slumped by 2589.66% to -$780000.0 in 2026.
- Business Quant data shows JAGX's Change in Inventory at -$780000.0 in Q1 2026, -$29000.0 in Q4 2025, and -$91000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | -780,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -780,000.00 |
| Mar 31, 2026 | -780,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Sep 30, 2025 | -91,000.00 |
| Sep 30, 2025 | -91,000.00 |
| Jun 30, 2025 | 165,000.00 |
| Jun 30, 2025 | 165,000.00 |
| Mar 31, 2025 | 209,000.00 |
| Mar 31, 2025 | 209,000.00 |
| Dec 31, 2024 | 671,000.00 |
| Dec 31, 2024 | 671,000.00 |
| Sep 30, 2024 | 118,000.00 |
| Sep 30, 2024 | 118,000.00 |
| Jun 30, 2024 | 536,000.00 |
| Jun 30, 2024 | 536,000.00 |
| Mar 31, 2024 | -169,000.00 |
| Mar 31, 2024 | -169,000.00 |
| Dec 31, 2023 | 810,000.00 |
| Dec 31, 2023 | 810,000.00 |